Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).
作者信息
Gutiérrez López de Ocáriz Xabier, Castro Quismondo Nerea, Vera Guerrero Elena, Rodríguez Rodríguez Mario, Ayala Díaz Rosa, Martínez López Joaquín
机构信息
Hospital Universitario 12 de Octubre, Madrid, España.
出版信息
Int J Lab Hematol. 2020 Dec;42(6):e280-e282. doi: 10.1111/ijlh.13320. Epub 2020 Aug 26.
Abstract
摘要
相似文献
1
Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).2019冠状病毒病（COVID-19）患者的血栓形成与抗磷脂抗体
Int J Lab Hematol. 2020 Dec;42(6):e280-e282. doi: 10.1111/ijlh.13320. Epub 2020 Aug 26.
2
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?抗磷脂抗体与危重症 COVID-19 患者的血栓并发症有关吗？
Thromb Res. 2020 Nov;195:74-76. doi: 10.1016/j.thromres.2020.07.016. Epub 2020 Jul 8.
3
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?抗磷脂抗体是否会导致新冠病毒病中的凝血病？
J Am Acad Dermatol. 2020 Sep;83(3):e249. doi: 10.1016/j.jaad.2020.06.003. Epub 2020 Jun 4.
4
Cautious interpretation of antiphospholipid antibodies in COVID-19.对新冠病毒肺炎中抗磷脂抗体的谨慎解读
Clin Chim Acta. 2020 Oct;509:166. doi: 10.1016/j.cca.2020.06.024. Epub 2020 Jun 15.
5
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.在 SARS-CoV-2 感染患者中出现抗磷脂抗体的频率和临床相关性：来自对 122 例病例进行的多中心研究的结果。
Clin Exp Rheumatol. 2020 Jul-Aug;38(4):754-759. Epub 2020 Jul 28.
6
Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.新冠危重症患者的灾难性抗磷脂抗体综合征及多器官功能障碍
Expert Rev Respir Med. 2020 Nov;14(11):1071-1072. doi: 10.1080/17476348.2020.1801427. Epub 2020 Aug 11.
7
Thrombosis and COVID-19 pneumonia: the clot thickens!血栓与 COVID-19 肺炎：凝块变厚！
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01608-2020. Print 2020 Jul.
8
Coagulopathy and mesenteric ischaemia in severe SARS-CoV-2 infection.重症严重急性呼吸综合征冠状病毒2感染中的凝血功能障碍和肠系膜缺血
ANZ J Surg. 2020 Sep;90(9):1826. doi: 10.1111/ans.16151. Epub 2020 Jul 13.
9
[Cerebral venous thrombosis and SARS-CoV-2 infection].[脑静脉血栓形成与新型冠状病毒2型感染]
Rev Neurol. 2020 May 16;70(10):391-392. doi: 10.33588/rn.7010.2020204.
10
Pulmonary Vascular Pathology in Covid-19.新冠病毒肺炎中的肺血管病理学
N Engl J Med. 2020 Aug 27;383(9):886-887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
引用本文的文献
1
COVID-19 coagulopathy and antiphospholipid syndrome.新型冠状病毒肺炎凝血病与抗磷脂综合征
Rev Colomb Reumatol. 2022 Jun;29:S25-S34. doi: 10.1016/j.rcreu.2021.02.013. Epub 2021 Aug 27.
2
The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.在患有肺炎和血管血栓形成的重症 COVID-19 病例中抗磷脂综合征的新出现可能解释 COVID 后综合征。
Biomedicines. 2025 Feb 19;13(2):516. doi: 10.3390/biomedicines13020516.
3
Antiphospholipid Antibodies and COVID-19: A Systematic Review of Clinical Implications.抗磷脂抗体与新型冠状病毒肺炎：临床意义的系统评价
Immun Inflamm Dis. 2025 Feb;13(2):e70134. doi: 10.1002/iid3.70134.
4
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature.由新型冠状病毒肺炎（COVID-19）引发的明确抗磷脂综合征：一例罕见病例报告及文献综述
Thromb J. 2024 Nov 8;22(1):99. doi: 10.1186/s12959-024-00669-6.
5
Effect of vitamin D on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19.维生素 D 对中重度 COVID-19 住院患者抗磷脂抗体的影响。
Clinics (Sao Paulo). 2024 Aug 27;79:100474. doi: 10.1016/j.clinsp.2024.100474. eCollection 2024.
6
IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients.IgA 抗β2-糖蛋白 I 抗体作为 COVID-19 患者血栓形成和严重程度的标志物。
Viruses. 2024 Jul 3;16(7):1071. doi: 10.3390/v16071071.
7
Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.抗磷脂抗体相关肝血管炎在非重症 COVID-19 后青少年中的发病：病例报告及文献复习。
Front Immunol. 2024 Apr 19;15:1354349. doi: 10.3389/fimmu.2024.1354349. eCollection 2024.
8
9
COVID-19 and antiphospholipid antibodies.COVID-19 与抗磷脂抗体。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101402. doi: 10.1016/j.beha.2022.101402. Epub 2022 Oct 15.
10
COVID-19 and the antiphospholipid syndrome.新型冠状病毒肺炎与抗磷脂综合征。
Autoimmun Rev. 2022 Dec;21(12):103206. doi: 10.1016/j.autrev.2022.103206. Epub 2022 Oct 3.
本文引用的文献
1
Coagulopathy of COVID-19 and antiphospholipid antibodies.新型冠状病毒肺炎的凝血功能障碍与抗磷脂抗体
J Thromb Haemost. 2020 Sep;18(9):E1-E2. doi: 10.1111/jth.14893. Epub 2020 May 28.
2
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
3
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
4
Characteristics of ischaemic stroke associated with COVID-19.与新型冠状病毒肺炎相关的缺血性卒中的特征
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891. doi: 10.1136/jnnp-2020-323586. Epub 2020 Apr 30.
5
Lupus anticoagulant is frequent in patients with Covid-19.狼疮抗凝物在新冠病毒肺炎患者中很常见。
J Thromb Haemost. 2020 Aug;18(8):2064-2065. doi: 10.1111/jth.14867. Epub 2020 May 11.
6
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
7
Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?炎症状态患者的狼疮抗凝物（LAC）检测：C反应蛋白会干扰LAC检测结果吗？
Thromb Res. 2010 Jan;125(1):102-4. doi: 10.1016/j.thromres.2009.09.001. Epub 2009 Sep 25.
Zotero 插件